Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Dec / Dropletronics
Technology and innovation Analytical science Screening and monitoring

Dropletronics

Biocompatible electronic devices open up new possibilities for in situ disease detection

By Helen Bristow 12/04/2024 News 1 min read

Share

Scientists at Oxford University’s Department of Chemistry have developed a set of biocompatible devices that use ions as the signal carriers. Made from soft hydrogel droplets, these “iontronic” devices are the first to be compatible for use with soft tissues. In the study published in Science, the team demonstrated the technology by recording electrical signals from beating human heart cells.

Credit: Yujia Zhang

Iontronics is a rapidly growing field of biochemical engineering. The devices transmit information via charged particles of sodium, potassium, and calcium, amongst others, mimicking cell signaling, which allows them to interface with cells and record signals from them. They have potential for many applications in clinical medicine, including sensing abnormalities in an organ and intelligent drug delivery inside the body.

Iontronics are typically set in solid scaffolds, so their integration with soft tissues has thus far been limited. The Oxford team, however, constructed their “dropletronics” by encasing tiny droplets in a surfactant-based organogel, creating a range of devices, including diodes, transistors, logic gates, and memory devices. In comparison with other soft iontronic devices, the dropletronic collection achieved superior response times and efficiencies. Performance of the dropletronics was comparable with solid iontronics, with the advantage of the flexible construct, which supports more applications within the body.

Credit: Yujia Zhang

The researchers tested dropletronics by creating a transistor to record electrophysiological signals from sheets of human heart cells. Co-author of the study, Christopher Toepfer, said, “This is the first example of a lab-built biological sensor that can sense and respond to changes in function of human heart cells in a dish. This finding is an exciting step towards the fabrication of more complex biological devices that will sense a variety of abnormalities in an organ and react by delivering drugs intelligently inside the body.”

Credit: Yujia Zhang

Credit: Yujia Zhang

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Technology and innovation
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Opening a Window into Brain Trauma
Technology and innovation
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Molecular Spectacular
Technology and innovation
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Cracking Colon Cancer
Technology and innovation
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.